Diablo Clinical Research   Report issue

For profit Phase 2 Phase 3
Founded: Walnut Creek CA United States (1995)

Organization Overview

First Clinical Trial
2007
NCT00409305
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Diablo Clinical Research, Inc.